tradingkey.logo
tradingkey.logo
Search

Enovis Corp

ENOV
Add to Watchlist
22.515USD
+2.475+12.35%
Close 07/02, 13:00ETQuotes delayed by 15 min
1.30BMarket Cap
LossP/E TTM

More Details of Enovis Corp Company

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp Info

Ticker SymbolENOV
Company nameEnovis Corp
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Number of employees7367
Security typeOrdinary Share
Fiscal year-endMay 08
Address2711 Centerville Road
CityWILMINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19808
Phone13022529160
Websitehttps://www.enovis.com/
Ticker SymbolENOV
IPO dateMay 08, 2008
CEOMcdonald (Damien)

Company Executives of Enovis Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

FAQs

Who are the top five shareholders of Enovis Corp?

The top five shareholders of Enovis Corp are: Mr. Daniel Alexis Pryor

How many institutions hold shares of Enovis Corp (ENOV)?

As of 2026Q1, 652 institutions hold shares of Enovis Corp, with a combined market value of approximately 68.97M, accounting for 119.81% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -6763998.00.

What is the biggest source of revenue for Enovis Corp?

In 2026Q1, the Medical Technology-Prevention & Rehabilitation business generated the highest revenue for Enovis Corp, amounting to 1.14B and accounting for 50.58% of total revenue.